September 26, 2017 5:38 AM ET


Company Overview of Accu-Break Pharmaceuticals, Inc.

Key Executives for Accu-Break Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Robert L. Goldfarb Esq.No RelationshipsPresident and General Counsel61
Elliot F. Hahn Ph.D.40 RelationshipsExecutive Chairman of the Board72
David Lucking No RelationshipsCo-Founder and Regulatory Consultant63
Lawrence Solomon M.D., FACCNo RelationshipsFounder--

Accu-Break Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Elliot F. Hahn Ph.D. 40 RelationshipsAccu-Break Pharmaceuticals, Inc.72
Nigel N. Norton 9 RelationshipsAccu-Break Pharmaceuticals, Inc.--
Marvin Moser M.D., F.a.c.p. F.a.c.c. 56 RelationshipsAccu-Break Pharmaceuticals, Inc.92
Michael A. Weber M.D., FACP, FACC, FAHA 50 RelationshipsPhaseBio Pharmaceuticals, Inc.--
Michael A. Schwartz Ph.D. 11 RelationshipsAccu-Break Pharmaceuticals, Inc.80
View All Board Members

Accu-Break Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D., F.a.c.p. F.a.c.c.Marvin Moser56 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Accu-Break Pharmaceuticals, Inc. CEO Compensation
Industry Average


SanBio Names Mohammad El-Kalay as Technical Operations SVP
September 25, 2017 1:30 AM ET
Pediapharm Inc. Announces Directorate Changes
September 22, 2017 11:30 PM ET
Kappac Pharma Ltd. Announces Board Changes
September 22, 2017 12:10 PM ET
Ampio Pharmaceuticals, Inc. Appoints Holli Cherevka as Chief Operating Officer, Effective September 19, 2017
September 22, 2017 10:01 AM ET
Bayer Announces Executive Changes
September 22, 2017 8:30 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Accu-Break Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at